Prof Hall is a population health researcher investigating the public health and public policy implications of neurobiological and genetic research on alcohol and other drug use and addiction. My research includes: the social and health system implications of new pharmacological treatments for addiction arising from neurobiological and genetic research; new approaches suggested for the prevention of drug use and addiction (for example, genetic screening and vaccination); and the impact of neurobi ....Prof Hall is a population health researcher investigating the public health and public policy implications of neurobiological and genetic research on alcohol and other drug use and addiction. My research includes: the social and health system implications of new pharmacological treatments for addiction arising from neurobiological and genetic research; new approaches suggested for the prevention of drug use and addiction (for example, genetic screening and vaccination); and the impact of neurobiological and genetic research findings on public understanding of, attitudes towards, and support for, different social policies that aim to deal with drug use and addiction.Read moreRead less
Evaluating The Effectiveness Of Future Tobacco Control Strategies
Funder
National Health and Medical Research Council
Funding Amount
$368,112.00
Summary
This research will evaluate promising new strategies to reduce the harm caused by tobacco, the leading preventable cause of premature death in Australia. This includes evaluation of general population-based strategies, such as public smoking bans, and interventions to help smokers quit smoking, such as new cessation aids and long-term maintenance on pharmaceutical nicotine or low-nitrosamine smokeless tobacco.
Transformed Drug Policies: Integrating Empirical Evidence With Participatory Democracy
Funder
National Health and Medical Research Council
Funding Amount
$782,370.00
Summary
In my 5 year research fellowship I will lead internationally relevant research on better policy options for illegal drugs, such as methamphetamine, heroin and cannabis. Drug policy can be driven by politics and the media, rather than research evidence. I will generate a cutting edge and fresh perspective with an agile approach to new research that takes into account the rapidly changing field of drug policy. This will provide policy makers with a new framework for evidence-based policy reforms.
Public Health Challenges And Opportunities Of Internet Technologies For The Study Of New And Emerging Psychoactive Substance Use And Related Health Harms
Funder
National Health and Medical Research Council
Funding Amount
$317,929.00
Summary
New psychoactive drugs that mimic the effects of prohibited drugs are increasingly available in Australia, and there is mounting evidence of their harmful health effects. This research examines the challenges and opportunities of internet technologies for understanding trends in new and emerging drug use and harms. Findings will inform the development of more effective public health responses to reduce morbidity and mortality from new psychoactive drugs and other illicit drug use.
The Ethics And Politics Of Pharmaceutical Innovation And Translation
Funder
National Health and Medical Research Council
Funding Amount
$476,728.00
Summary
I lead a research program on the ethics and politics of pharmaceutical innovation and translation: how medicines are developed, regulated, funded and taken up into practice. I aim to help policymakers to deal with conflicts among stakeholders. Over the next 4 years I will conduct a suite of research projects on topics of immediate significance to Australian policymakers; develop a new framework for pharmaceutical ethics and create a “Pharmaceutical Ethics and Politics Network.”
Enhancing Hepatitis C Testing And Treatment Among People Who Inject Drugs In Drug Treatment Settings: The ETHOS III Study
Funder
National Health and Medical Research Council
Funding Amount
$1,349,604.00
Summary
Progress towards hepatitis C elimination has been slowed. Given that most people with hepatitis C have a history of injecting drug use, reducing hepatitis C burden requires scale-up of enhanced testing and treatment for people who inject drugs. This Partnership project will evaluate an intervention to enhance hepatitis C testing and treatment in drug treatment clinics and develop a translational framework to scale-up hepatitis C care in this setting nationally.
The Cost Effectiveness Of Improving Health And Reducing Offending Among Recently Released Prisoners In Australia
Funder
National Health and Medical Research Council
Funding Amount
$328,750.00
Summary
Ex-prisoners face high risk of poor health and social outcomes in the community, and Indigenous people are over-represented in prison population by a factor of 15. The ‘Passports to Advantage’ intervention aims to improve the capacity of ex-prisoners, to use health care and community support services. Nationwide adoption of the intervention will be costly, but can change health service use and health outcomes among ex-prisoners. There is currently no evidence to address the policy decision of wh ....Ex-prisoners face high risk of poor health and social outcomes in the community, and Indigenous people are over-represented in prison population by a factor of 15. The ‘Passports to Advantage’ intervention aims to improve the capacity of ex-prisoners, to use health care and community support services. Nationwide adoption of the intervention will be costly, but can change health service use and health outcomes among ex-prisoners. There is currently no evidence to address the policy decision of whether the intervention should be widely adopted.Read moreRead less
An Integrated Research Program In Clincial Toxicology Toxicovigilance And Treatment
Funder
National Health and Medical Research Council
Funding Amount
$568,892.00
Summary
Drug-related deaths in Australia account for 6.6% of all deaths (ABS 2009). In much of the rural Asia-Pacific, pesticide poisoning and snakebite are major problems. This research supports an integrated national and international clinical toxicology research program covering medicine and chemical poisoning, serious adverse drug reactions, snake and spider bite. Its focus is on the applied research needed to detect new problems and rapidly translate early findings into better treatment, regulation ....Drug-related deaths in Australia account for 6.6% of all deaths (ABS 2009). In much of the rural Asia-Pacific, pesticide poisoning and snakebite are major problems. This research supports an integrated national and international clinical toxicology research program covering medicine and chemical poisoning, serious adverse drug reactions, snake and spider bite. Its focus is on the applied research needed to detect new problems and rapidly translate early findings into better treatment, regulations & policy.Read moreRead less
Enhancing Treatment Of Hepatitis C In Opioid Substitution Settings II (ETHOS II): A Partnership Project To Enhance Hepatitis C Care In Drug And Alcohol Clinics
Funder
National Health and Medical Research Council
Funding Amount
$1,265,716.00
Summary
This Partnership Project will evaluate novel strategies to enhance care for hepatitis C infection in drug and alcohol clinics. Based on a foundation of strong, existing partnerships, this project has considerable potential to facilitate the translation of research outcomes into policy and practice and facilitate the scale-up of hepatitis C care in drug and alcohol clinics in NSW and nationally.